Why Attend:

* Learn the current issues facing drug manufacturers in Europe and North America in regard to pricing and reimbursement

* Better understand the trends of generic pricing in Europe

* Learn from experts on how to effectively price products in the EU and North America

* Determine key strategies to assist in the management of pricing and reimbursement in an increasing globalising world

* Network with leaders from regulatory agencies, pharma-biotech and healthcare industries

Conference Topics and Confirmed Speakers

--Pricing of Pharmaceuticals in Europe--

Dr Jorge Mestre-Ferrandiz, Senior Economist, Office of Health Economics, Whitehall, London, UK

---Comparative Assessment of Generic Medicines---

Professor Steven Simoens, Research Centre for Pharmaceutical Care and Pharmaco-economics, Katholieke Universiteit Leuven, Belgium

---NICE and Risk Sharing/Capping Schemes---

Dr Kalipso Chalkidou, Associate Director of Research and Development, National Institute for Clinical Effectiveness, London, UK


---Health Economics in the Era of Biologics---

Mr Ulf Staginnus, Associate Director Outcomes Research Iberia and EMEA, Spain

---Managing the Complexity of Pricing and Reimbursement in a Globalizing World---

Dr Dieter Russmann, Vice President Global Customer Strategy, Service Leader, Pricing & Reimbursement Europe, PAREXEL Consulting, Germany


Who Should Attend

Individuals from the following industries:

* Regulatory Agency Executives
* Pharmaceutical companies
* Biotechnology companies
* Specialty pharmaceutical companies
* Medical device manufacturers
* Investment and capital markets community

Individuals from the following areas/departments will greatly benefit from attending:

* Executive management
* Corporate development
* Regulatory executives
* Pricing executives
* Commercial development executives
* New product planning executives
* Legal professionals
* Licensing personnel
* Intellectual property specialists
* Strategic planning & development
* Marketing executives
* R&D executives